Meta-analysis of specific immunotherapy in patients with allergic rhinoconjunctivitis;Die spezifische immuntherapie (hyposensibilisierung) bei allergischer rhinokonjunktivitis. Metaanalyse zu wirksamkeit und nebenwirkungen

HNO

Volumn 47, Issue 7, 1999, Pages 602-610

  Klimek, L ^a   Malling, H J ^a  

^a NONE

Author keywords

Allergic rhinoconjunctivitis; Specific immunotherapy

Indexed keywords

ALLERGEN; ANTIBODY; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 4; INTERLEUKIN 5;

ALLERGIC RHINITIS; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IMMUNOTHERAPY; POLLEN; PROVOCATION TEST; REVIEW; RHINOCONJUNCTIVITIS; T LYMPHOCYTE;

CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; HUMANS; INTERLEUKIN-4; NASAL PROVOCATION TESTS; RANDOMIZED CONTROLLED TRIALS; RHINITIS, ALLERGIC, SEASONAL; TH2 CELLS; TREATMENT OUTCOME;

EID: 0032799294     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001060050433     Document Type: Review

References (74)

1. Ariano R, Panzani RC, Augeri G (1997) Double-blind, placebo-controlled specific immunotherapy with mixed Cupressaceae Taxodiaceae pollens in respiratory allergy to Cupressus sempervirens. Allergol Immunpathol (Madr) 25:23-29
2. Blainey AD, Philips MJ, Ollier RJ, Davies RJ (1984) Hyposensitization with a tyrosine adsorbed extract of Dermatophagoides pteronyssinus in adults with perennial rhinitis. Allergy 39:521-528
3. Bousquet J, Becker WM, Hejjaoui A, Chanal I, Lebel B, Dhivert H, Michel FB (1991) Differences in clinical and immunologic reactivity of patients allergic to grass pollens and to multiple-pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts. J Allergy Clin Immunol 88:43-53
4. Bousquet J, Frank E, Soussana M, Hejjaoui A, Maasch HJ, Michel FB (1987) Double-blind, placebo-controlled immunotherapy with a high-molecular-weight, formalinized allergoid in grass pollen allergy. Int Arch Allergy Appl Immunol 82:550-552
5. Bousquet J, Hejjaoui A, Skassa Brociek W, Guerin B, Maasch HJ, Dhivert H, Michel FB (1987) Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. I. Rush immunotherapy with allergoids and standardized orchard grass-pollen extract. J Allergy Clin Immunol 80:591-598
6. Bousquet J, Hejjaoui A, Soussana M, Michel FB (1990) Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight alergoid. J Allergy Clin Immunol 85:490-497
7. Bousquet J, Maarch H, Martinot B, Hejjaoui A, Wahl R, Michel FB (1988) Double blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing efficacy of immunotherapy. J Allergy Clin Immunol 82:439-446
8. Bousquet J, Maasch HJ, Hejjaoui A, Skassa Brociek W, Wahl R, Dhivert H, Michel FB (1989) Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. III. Efficacy and safety of unfractionated and high-molecular-weight preparations in rhinoconjunctivitis and asthma. J Allergy Clin Immunol 84:546-556
9. Bronsky EA, Dockhorn RJ, Meltzer EO et al. (1996) Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 97:915-921
10. Brunet C, Bédard P-M, Lavoie A, Jobin M, Hébert J (1992) Allergic rhinitis to ragweed pollen. I. Reassessment of the effects of immunotherapy on cellular and humoral responses. J Allergy Clin Immunol 89:76-86
11. Bucur J, Dreborg S, Einarsson R (1989) Immunotherapy with dog and cat allrgen preparaions in dog-sensitive and cat-sensitive asthmatics. Ann Allergy 62:355-361
12. Corrado OJ, Pastorello E, Ollier RJ et al. (1989) A double-blind study of hyposensitization with an alginate conjugated extract of D. pteronyssinus (ConjuvacR) in patients with perennial rhinitis. 1. Clinical aspects. Allergy 44:108-115
13. D'Amato G, Kordash TR, Liccardi G, Lobefalo G, Cazzola M, Freshwater LL (1995) Immunotherapy with Alpare® in patients with respiartory allergy to Parietaria pollen: a two year double-blind placebo-controlled study. Clin Exp Allergy 25:149-158
14. Del Prete GF, De Carli M, D'Elios MM, Maestrelli P, Ricci M, Fabbri L, Romagnani S (1993) Allergen exposure induces the activation of allergen-specific Th2-cells in the airway mucosa of patients with allergic respiratory disorders. Eur J Immunol 23:1445
15. Dolz I, Martinez-Cócera C, Bartolomé JM, Cimarra M (1996) A double-blind, placebo-controlled study of immunotherapy with grass-pollen extract Alutard SQ during a 3-year period with initial rush imunotherapy. Allergy 51:489-500
16. Dreborg S, Frew A (1998) Allergen standardization and skin tests. Allergy 48:49-82
17. Ewan PW, Alexander MM, Snape C, Ind PW, Agrell B, Dreborg S (1988) Effective hyposensitization in allergic rhinitis using a potent partially purified extract of house dust mite. Clin Allergy 18:501-508
18. Fling JA, Ruff ME, Parker WA, Whisman BA, Martin ME, Moss RB, Reid MJ (1989) Suppression of the late cutaneous response by immunotherapy. J Allergy Clin Immunol 83:101-109
19. Fuchs T, Klimek L (1999) Die allergenspezifische Immuntherapie (Hyposensibilisierung). Teil 2: Orale, sublinguale und nasale Applikation. HNO (im Druck)
20. Furin MJ, Norman PS, Creticos PS, Proud D, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM (1991) Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity. J Allergy Clin Immunol 88:27-32
21. Grammer LC, Shaughnessy MA, Bernhard MI, Finkle SM, Pyle HR, Silvestri L, Patterson R (1987) The safety and activity of polymerized ragweed: a double-blind, placebo-controlled trial in 81 patients with ragweed rhinitis. J Allergy Clin Immunol 80:177-183
22. Grammer LC, Shaughnessy MA, Finkle SM, Shaughnessy JJ, Patterson R (1986) A double-blind placebo-controlled trial of polymerized whole grass administered in an accelerated dosage schedule for immunotherapy of grass pollinosis. J Allergy Clin Immunol 78:1180-1184
23. Grammer LC, Shaughnessy MA, Shaughnessy JJ, Patterson R (1984) Asthma as a variable in a study of immunotherapy for allergic rhinitis. J Allergy Clin Immunol 73:557-560
24. Grammer LC, Shaughnessy MA, Suszko IM, Shaughnessy JJ, Patterson R (1983) A double-blind histamine placebo-controlled trial of polymerized whole grass for immunotherapy of grass allergy. J Allergy Clin Immunol 72:448-453
25. Grammer LC, Zeiss CR, Suszko IM, Shaughnessy MA, Patterson R (1982) A double-blind placebo-controlled trial of polymerized whole ragweed for immunotherapy of ragweed allergy. J Allergy Clin Immunol 69:494-499
26. Haugaard L, Dahl R, Jacobsen L (1993) A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: clinical efficacy and side effects. J Allergy Clin Immunol 91:709-722
27. Hejjaoui A, Ferrando R, Dhivert H, Michel FB, Bousquet J (1992) Systemic reactions occuring during immunotherapy with standardized pollen extracts. J Allergy Clin Immunol 89:925-933
28. Hirsch SR, Kalbfleisch JH, Golbert TM et al. (1981) Rinkel injection therapy: a multicenter controlled study. J Allergy Clin Immunol 68:133-155
29. Horst M, Hejjaoui A, Horst V, Michel F-B, Bousquet J (1990) Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract. J Allergy Clin Immunol 85:460-472
30. Iliopoulos O, Proud D, Adkinson NF Jr et al. (1991) The effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells. J Allergy Clin Immunol 87:855-866
31. Jacobsen L, Nüchel Petersen B, Wihl JÅ, Løwenstein H, Ipsen H (1997) Immunotherapy with partially purified and standardized tree pollen extracts. IV. Results from long-term (6-year) follow up. Allergy 52:914-920
32. Juniper EF, Kline PA, Ramsdale EH, Hargreave FE (1990) Comparison of the efficacy and side effects of aqueous steroid nasal spray (budesonide) and allergen-injection therapy (Polinex-R) in the treatment of seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 85:606-611
33. Juniper EF, Roberts RS, Kennedy LK, O'Connor J, Syty-Golda M, Dolovich J, Hargreave FE (1985) Polyethylene glycol-modified ragweed pollen extract in rhinoconjunctivitis. J Allergy Clin Immunol 75:578-585
34. Karmakar PR, Das A, Chatterjee BP (1994) Placebo-controlled immunotherapy with Cocos nucifera pollen extract. Int Arch Allergy Immunol 103:194-201
35. Klimek L (1999) Die allergenspezifische Immuntherapie (Hyposensibilisierung). Teil 1: Grundlagen und subkutane Applikation. HNO (im Druck)
36. Klimek L, Mewes T, Mann W, Bollessen M, Wolf H (1997) Short-term immunotherapy (STI) is able to reduce allergeninduced eosinophil and mast-cell degranulation in grass pollen rhinitis. Allergy 52 [Suppl 37]: 153
37. Klimek L, Wolf H, Mewes T, Dormann D, Reske-Kunz AB, Schnitker J, Mann W (1999) The effect of short-term immunotherapy with molecular standardized grass and rye allergens on eosinophil cationic protein and tryptase in nasal secretions. J Allergy Clin Immunol 103:47-53
38. Lee LK, Kniker WT, Campos T (1982) Aggressive coseasonal immunotherapy in mountain cedar pollen allergy. Arch Otolaryngol 108:787-794
39. Litwin A, Pesce GP, Fischer T, Michael M (1991) Regulation of the human immune response to ragweed pollen by immunotherapy. A controlled trial comparing the effect of immmunosuppressive peptic fragments of short ragweed with standard treatment. Clin Exp Allergy 21:457-465
40. Machiels JJ, Somville MA, Jacquemin MG, Saint-Remy JMR (1991) Allergen-antibody complexes can efficiently prevent seasonal rhinitis and asthma in grass pollen hypersensitive patients. Allergy 46:335-348
41. Maggi E, Parronchi P, Manetti R et al. (1992) Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. J Immunol 148:2142
42. Malling HJ (1993) Methods of skin testing. Position paper: allergen standardization and skin tests. EACCI Executive Committee. Allergy 47 [Suppl 14]:55-56
43. Malling HJ, Weeke B (1993) Position Paper Immunotherapy of the EAACI. Allergy 48:9-35
44. McHugh SM, Ewan PW (1989) Reduction of increased serum neutrophil chemotactic activity following effective hyposensitization in house dust mite allergy. Clin Exp Allergy 19:327-334
45. McHugh SM, Lavelle B, Kemeny DM, Patel S, Ewan PW (1990) A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, ang IgG subclasses. J Allergy Clin Immuno 86:521-532
46. Meriney DK, Kothari H, Chinoy P, Grieco MH (1986) The clinical and immunologic efficacy of immunotherapy with modified ragweed extract (allergoid) for ragweed hay fever. Ann Allergy 56:34-38
47. Metzger WJ, Dorminey HC, Richerson HB, Weiler JM, Donnelly A, Moran D (1981) Clinical and immunologic evaluation of glutaraldehyde-modified, tyrosine-absorbed short ragweed extract: a double-blind, placebo-controlled trial. J Allergy Clin Immunol 68:442-448
48. Mosmann TR, Sad S (1996) The expanding universe of T-cell subsets. Th1, Th2 and more. Immunol Today 17:138
49. Norman PS, Lichtenstein LM, Kagey-Sobotka A, Marsh DG (1982) Controlled evaluation of allergoid in the immunotherapy of ragweed hay fever. J Allergy Clin Immunol 70:248-260
50. Nüchel Petersen B, Janniche H, Munch EP, Wihl JÅ, Böwadt H, Ipsen H, Løwenstein H (1988) Immunotherapy with partially purified and standardized tree pollen extracts. I. Clinical results from a three-year double-blind study of patients treated with pollen extracts either of birch or combinations of alder, birch and hazel. Allergy 43:353-362
51. Ortolani C, Pastorello E, Moss RB et al. (1984) Grass pollen immunotherapy: a single year double-blind, placebo-controlled study in patients with grass pollen-induced asthma and rhinitis. J Allergy Clin Immunol 73:283-290
52. Ortolani C, Pastorello EA, Incorvaia A et al. (1994) A double-blind, placebo-controlled study of immunotherapy with an alginate-conjugated extract of Parietaria judaica in patients with Parietaria hay fever. Allergy 49:12-21
53. Østerballe O (1982) Immunotherapy with grass pollen major allergens. Allergy 37:379-388
54. Parker WA, Whisman BA, Apaliski SJ, Reid MJ (1989) The relationships between late cutaneous responses and specific antibody responses with outcome of immunotherapy for seasonal allergic rhinitis. J Allergy Clin Immunol 84:667-677
55. Pastorello E, Pravettoni V, Mambretti M, Franck E, Wahl R, Zanussi C (1992) Clinical and immunological effects of immunotherapy with alum-absorbed grass allergoid in grass-pollen-induced hay fever. Allergy 47:281-290
56. Pene J, Rousset F, Briere F et al. (1988) IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-gamma. J Immunol 141:1218-1224
57. Rak S, Löwenhagen O, Venge P (1988) The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients. J Allergy Clin Immunol 82:470-480
58. Reid MJ, Lockey RF, Turkeltaub PC, Platts-Mills TAE (1993) Survey of fatalities from skin testing and immunotherapy 1985-1989. J Allergy Clin Immunol 92:6-15
59. Reske-Kunz AB, Klimek L, Saloga J (1997) Theorien zur Wirkweise der Hyposensibilisierung. In: Klimek, L, Saloga, J, Reske-Kunz AB (Hrsg) Die spezifische Hyposensibilisierungsbehandlung.Thieme, Stuttgart New York
60. Robinson DS, Hamid QA, Ying S et al. (1992) Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 326:298
61. Romagnani S (1994) Regulation of the development of type 2 T-helper cells in allergy. Curr Opin Immunol 6:838-843
62. Sadan N, Rhyne MB, Mellits ED, Goldstein O, Levy DA, Lichtenstein LM (1969) Immunotherapy of pollinosis in children. Investigation of the immunologic basis of clinical improvement. N Engl J Med 280:623
63. Scadding GK, Lund VJ, Jacques LA, Richards DH (1995) A placebo-controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: efficacy in allergic and non-alleric perennial rhinitis. Clin Exp Allergy 25:737-743
64. Schadewaldt H (1988) Zur Geschichte der Allergie. In: Fuchs E, Schulz KH (Hrsg) Manuale allergologicum. Dustri, Deisenhofen, S1-18
65. Stewart IGE, Lockey RF (1992) Systemic reactions from allergen immunotherapy. J Allergy Clin Immunol 90:567-578
66. Tabar AI, Garcia BE, Rodriguez A, Olaguibel JM, Muro MD, Quirce S (1993) A prospective safety-monitoring study of immunotherapy with biologically standardizd extracts. Allergy 48:450-453
67. Tari MG, Mancino M, Ghezzi E, Frank E, Cromwell O (1997) Immunotherapy with a alum-adsorbed Parietaria-pollen allergoid: a 2-year, double-blind, placebo-controlled study. Allergy 52:65-74
68. Van Metre TE, Adkinson NF, Lichtenstein LM et al. (1980) A controlled study of the effectiveness of the Rinkel method of immunotherapy for ragweed pollen hay fever. J Allergy Clin Immunol 65:288-297
69. Van Metre TE, Franklin Adkinson N, Amodio FJ et al. (1982) A comparison of immunotherapy schedules for injection treatment of ragweed pollen hay fever. J Allergy Clin Immunol 69:181-193
70. Varney VA, Gaga M, Frew AJ, Aber VR, Kay AB, Durham SR (1991) Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. Br Med J 302:265-269
71. Varney VA, Hamid QA, Gaga M et al. (1993) Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 92:644-651
72. Walker SM, Varney VA, Gaga M, Jacobson M, Durham SR (1995) Grass pollen immunotherapy: efficacy and safety during a 4-year follow-up study. Allergy 50:405-413
73. Weyer A, Donat N, L'Heritier C, Juillard F, Pauli G, David B (1981) Grass pollen hyposensitization versus placebo therapy. I. Clinical effectiveness and methodological aspects of a pre-seasonal course of desensitization with a four-grass pollen extract. Allergy 36:309-317
74. Zenner HP, Baumgarten C, Rasp G et al. (1997) Short-term immunotherapy: a prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis. J Allergy Clin Immunol 100:23-29